Literature DB >> 15378289

The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study.

Giovanni La Montagna1, Antonio Sodano, Vittorio Capurro, Domenico Malesci, Gabriele Valentini.   

Abstract

OBJECTIVE: To assess the clinical and radiological features of systemic sclerosis (SSc) joint involvement in a prospective cross-sectional study. DESIGN AND PATIENTS: Seventy-six consecutive patients with SSc divided into clinical and serological subsets were investigated. Clinical and radiological assessments of the hands and feet were carried out. Three radiological patterns of inflammatory, degenerative and fibrotic changes were predefined. The Health Assessment Questionnaire (HAQ) disability index (DI) and individual components of the HAQ-DI were also evaluated.
RESULTS: The highest impairments on the HAQ-DI (median 0.44; range 0-2.87) were detected in subdimensions such as hygiene, grip and activity components. Clinically articular involvement, arthralgia and finger contractures were seen more frequently than arthritis, and a significantly higher prevalence of finger flexion was found in patients with diffuse cutaneous SSc (P=0.03) compared with the other SSc subtypes. Radiologically, distal interphalangeal joint space narrowing and flexion deformity indicating periarticular fibrosis were frequently detected. Juxta-articular osteoporosis, joint space narrowing and flexion contractures of the fingers were seen significantly more frequently in the hands. A significantly higher frequency of fibrotic pattern were found in the hands whereas a degenerative pattern was more frequent in the feet (P<0.05). Finally, significant correlations were detected between flexion contractures and a radiological fibrotic pattern (P<0.001), and the severity scores of peripheral vascular impairment (P=0.026) and skin (P=0.007).
CONCLUSION: This cross-sectional prospective study confirms that an arthropathy is common in SSc patients and shows that it is a major determinant of disability. A classification of radiological alterations into three specific patterns is proposed.

Entities:  

Mesh:

Year:  2004        PMID: 15378289     DOI: 10.1007/s00256-004-0830-6

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  30 in total

Review 1.  Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

Authors:  Clodoveo Ferri; Gabriele Valentini; Franco Cozzi; Marco Sebastiani; Claudio Michelassi; Giovanni La Montagna; Arianna Bullo; Massimiliano Cazzato; Enrico Tirri; Franca Storino; Dilia Giuggioli; Giovanna Cuomo; Mara Rosada; Stefano Bombardieri; Silvano Todesco; Giuseppe Tirri
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

2.  Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival.

Authors:  Lilian Scussel-Lonzetti; France Joyal; Jean-Pierre Raynauld; André Roussin; Eric Rich; Jean-Richard Goulet; Yves Raymond; Jean-Luc Senécal
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

Review 3.  Assessment of vascular involvement.

Authors:  B Kahaleh; O Meyer; R Scorza
Journal:  Clin Exp Rheumatol       Date:  2003       Impact factor: 4.473

Review 4.  Non organ based laboratory markers in systemic sclerosis.

Authors:  N J McHugh; O Distler; R Giacomelli; G Riemekasten
Journal:  Clin Exp Rheumatol       Date:  2003       Impact factor: 4.473

Review 5.  Conclusion and identification of the core set of variables to be used in clinical investigations.

Authors:  G Valentini; T A Medsger; A J Silman; S Bombardieri
Journal:  Clin Exp Rheumatol       Date:  2003       Impact factor: 4.473

6.  Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis.

Authors:  M Jinnin; H Ihn; K Yamane; Y Asano; N Yazawa; K Tamaki
Journal:  Clin Exp Rheumatol       Date:  2003 Jan-Feb       Impact factor: 4.473

7.  Synovial tissue changes and rheumatoid factor in scleroderma.

Authors:  J A Clark; R K Winkelmann; F C McDuffie; L E Ward
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Arthritis in scleroderma.

Authors:  R Misra; K Darton; R F Jewkes; C M Black; R N Maini
Journal:  Br J Rheumatol       Date:  1995-09

10.  Scleroderma and erosive polyarthritis: a disease entity?

Authors:  R D Armstrong; T Gibson
Journal:  Ann Rheum Dis       Date:  1982-04       Impact factor: 19.103

View more
  17 in total

1.  Radiological hand involvement in systemic sclerosis.

Authors:  J Avouac; H Guerini; J Wipff; N Assous; A Chevrot; A Kahan; Y Allanore
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

Review 2.  Is there evidence for vasculitis in systemic sclerosis?

Authors:  Lesley Ann Saketkoo; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 3.  Ultrasound in systemic sclerosis. A multi-target approach from joint to lung.

Authors:  Marwin Gutierrez; Carlos Pineda; Tomas Cazenave; Marco Piras; Gian Luca Erre; Antonella Draghessi; Rossella De Angelis; Walter Grassi
Journal:  Clin Rheumatol       Date:  2014-02-18       Impact factor: 2.980

4.  Anti-cyclic citrullinated peptide antibodies in scleroderma patients.

Authors:  M Polimeni; D Feniman; T S Skare; Renato M Nisihara
Journal:  Clin Rheumatol       Date:  2012-01-04       Impact factor: 2.980

5.  Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis.

Authors:  M M Sampaio-Barros; J C Alvarenga; L Takayama; A P L Assad; P D Sampaio-Barros; R M R Pereira
Journal:  Osteoporos Int       Date:  2019-04-27       Impact factor: 4.507

6.  Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis.

Authors:  Francesca Ingegnoli; Valentina Galbiati; Silvana Zeni; Laura Meani; Lenka Zahalkova; Chiara Lubatti; Amedeo Soldi; Erberto Paresce; Antonella Murgo; Calogero Crapanzano; Flavio Fantini
Journal:  Clin Rheumatol       Date:  2006-05-03       Impact factor: 2.980

7.  Association of radiographic findings in hand X-ray with clinical features and autoantibodies in patients with systemic sclerosis.

Authors:  Komei Sakata; Yuko Kaneko; Hidekata Yasuoka; Tsutomu Takeuchi
Journal:  Clin Rheumatol       Date:  2019-06-18       Impact factor: 2.980

8.  Evaluating hand in systemic sclerosis.

Authors:  Didem Arslan Tas; Eren Erken; Hakan Sakalli; A Eftal Yucel
Journal:  Rheumatol Int       Date:  2011-11-17       Impact factor: 2.631

9.  Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study.

Authors:  Karen Au; Maureen D Mayes; Paul Maranian; Philip J Clements; Dinesh Khanna; Virginia D Steen; Donald Tashkin; Michael D Roth; Robert Elashoff; Daniel E Furst
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-12       Impact factor: 4.794

Review 10.  Laryngeal Involvement in Connective Tissue Disorders. Is it Important for Patient Management?

Authors:  Emily Iacovou; Petros V Vlastarakos; Thomas P Nikolopoulos
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.